MedPath

A Study to Evaluate the Efficacy and Safety of Local administration of Indocyanine Green in Surgery for Colorectal Neoplasm

Phase 2
Recruiting
Conditions
colorectal cancer
Registration Number
JPRN-jRCTs031220639
Lead Sponsor
Ishihara Soichiro
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
33
Inclusion Criteria

(1) With a histological diagnosis of colorectal cancer
(2) Scheduled to have any surgery for the colorectal cancer
(3) With an ECOG performance status of 0 or 1
(4) Aged 18 years and above at the time of informed consent is taken
(5) Male or female
(6) Able and willing to give written informed consent with sufficient understanding after having received sufficient explanation

Exclusion Criteria

(1) With allergy to indocyanine green
(2) With iodine allergy or with allergy to iodine contrast
(3) With severe liver failure, renal failure, or cardiac disease
(4) With bowel obstruction
(5) With intraperitoneal infection (e.g. peritonitis or intraperitoneal abscesses)
(6) Difficult colonoscopy
(7) Having a history of severe drug allergy or severe side effects
(8) Pregnant, unwilling to practice contraception during the study, or lactating female
(9) Judged as ineligible by clinical investigators

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath